Clinical trials: Intravenous Lidocaine
Healthy
Pharmacokinetic Study of Lidocaine Patch 1.8% Lidocaine Patch 5% (Lidoderm®) in Healthy Subjects
The purpose of this study is to characterize the comparative single-dose pharmacokinetics (bioequivalence) of lidocaine patch 1.8% (investigational product) versus Lidoderm® (lidocaine patch 5%,reference product).
- Trial name
- NCT04144192
- Testing
- Lidocaine patch 1.8%, Lidocaine 5% patch, Lidocaine 2% Injectable Solution
- Volunteers
- 58 people, healthy volunteers welcome
- Sponsor
- Scilex Pharmaceuticals, Inc.